| Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy A Babu, N Amreddy, R Muralidharan, G Pathuri, H Gali, A Chen, YD Zhao, ... Scientific reports 7 (1), 14674, 2017 | 97 | 2017 |
| Small-molecule inhibition of GCNT3 disrupts mucin biosynthesis and malignant cellular behaviors in pancreatic cancer CV Rao, NB Janakiram, V Madka, G Kumar, EJ Scott, G Pathuri, T Bryant, ... Cancer research 76 (7), 1965-1974, 2016 | 49 | 2016 |
| Synthesis and in vivo evaluation of p-18F-Fluorohippurate as a new radiopharmaceutical for assessment of renal function by PET V Awasthi, G Pathuri, HB Agashe, H Gali Journal of Nuclear Medicine 52 (1), 147-153, 2011 | 41 | 2011 |
| Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention NS Yarla, H Gali, G Pathuri, S Smriti, M Farooqui, J Panneerselvam, ... Seminars in cancer biology 56, 168-174, 2019 | 31 | 2019 |
| Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo G Pathuri, AF Hedrick, BC Disch, JT Doan, MA Ihnat, V Awasthi, H Gali Bioconjugate chemistry 23 (1), 115-124, 2012 | 30 | 2012 |
| Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer S Elayapillai, S Ramraj, DM Benbrook, M Bieniasz, L Wang, G Pathuri, ... Gynecologic oncology 160 (1), 302-311, 2021 | 29 | 2021 |
| HClO4–SiO2 as a novel and recyclable catalyst for the one-pot synthesis of homoallylic amines L Nagarapu, V Paparaju, G Pathuri, S Kantevari, RR Pakkiru, R Kamalla Journal of Molecular Catalysis A: Chemical 267 (1-2), 53-56, 2007 | 25 | 2007 |
| Renogram comparison of p-[18F] fluorohippurate with o-[125I] iodohippurate and [99mTc] MAG3 in normal rats G Pathuri, K Sahoo, V Awasthi, H Gali Nuclear medicine communications 32 (10), 908-912, 2011 | 19 | 2011 |
| Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting αvβ3 integrin expression G Pathuri, K Sahoo, V Awasthi, H Gali Bioorganic & medicinal chemistry letters 20 (20), 5969-5972, 2010 | 18 | 2010 |
| Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer A Mohammed, NB Janakiram, V Madka, G Pathuri, Q Li, R Ritchie, ... Oncotarget 8 (58), 97822, 2017 | 17 | 2017 |
| Molecular Mechanisms of Cancer Prevention by Gooseberry (Phyllanthus emblica) G Kumar, V Madka, G Pathuri, V Ganta, CV Rao Nutrition and cancer 74 (7), 2291-2302, 2022 | 16 | 2022 |
| Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1, 2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APCMin/+ mice G Pathuri, Q Li, A Mohammed, H Gali, JT Pento, CV Rao Bioorganic & medicinal chemistry letters 24 (5), 1380-1382, 2014 | 16 | 2014 |
| Molecular targets in precision chemoprevention of colorectal cancer: an update from pre-clinical to clinical trials NS Yarla, V Madka, G Pathuri, CV Rao International Journal of Molecular Sciences 21 (24), 9609, 2020 | 15 | 2020 |
| Single-step radiosynthesis and in vivo evaluation of a novel fluorine-18 labeled hippurate for use as a PET renal agent G Pathuri, AF Hedrick, V Awasthi, H Gali Nuclear medicine and biology 39 (8), 1195-1201, 2012 | 15 | 2012 |
| Synthesis and in vivo evaluation of gallium‐68‐labeled glycine and hippurate conjugates for positron emission tomography renography G Pathuri, AF Hedrick, SE January, WK Galbraith, V Awasthi, CD Arnold, ... Journal of Labelled Compounds and Radiopharmaceuticals 58 (1), 14-19, 2015 | 11 | 2015 |
| Synthesis of 3-(Glycosyloxymethyl) isocoumarins and (S)-3-(Glycosyloxymethyl)-3, 4-dihydroisocoumarins by Coupling of Propargyl Glycosides with 2-Iodobenzoic Acid Mediated by … HB Mereyala, G Pathuri Synthesis 2006 (17), 2944-2950, 2006 | 11 | 2006 |
| Discovery and development of a novel mPGES-1/5-LOX dual inhibitor LFA-9 for prevention and treatment of chronic inflammatory diseases NS Yarla, G Pathuri, H Gali, S Terzyan, J Panneerselvam, ... Journal of Inflammation Research, 1261-1278, 2020 | 10 | 2020 |
| Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells NB Janakiram, A Mohammed, M Brewer, T Bryant, L Biddick, S Lightfoot, ... Cancer Prevention Research 7 (3), 300-309, 2014 | 10 | 2014 |
| Development of a dietary formulation of the SHetA2 chemoprevention drug for mice DM Benbrook, NB Janakiram, V Chandra, G Pathuri, V Madka, ... Investigational new drugs 36, 561-570, 2018 | 9 | 2018 |
| Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor G Pathuri, JE Thorpe, BC Disch, LC Bailey-Downs, MA Ihnat, H Gali Bioorganic & medicinal chemistry letters 23 (12), 3561-3564, 2013 | 9 | 2013 |
